Paclitaxel Injection Market in-Depth Analysis by Top Manufacturers (2019-2026): Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E, Taj Accura
The global Paclitaxel Injection market was valued at $2200 million in 2019, and our analysts predict the global market size will reach $4960 million by the end of 2026, growing at a CAGR of 7.67% between 2019 and 2026.
View full press release